SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-24-000051
Filing Date
2024-05-24
Accepted
2024-05-24 16:10:50
Documents
3
Period of Report
2024-05-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716581426.html 4  
1 FORM 4 wk-form4_1716581426.xml 4 4033
2 EX-24 mrewolinskipoav2.htm EX-24 11783
3 mrewolinskipoav2001.jpg GRAPHIC 227636
  Complete submission text file 0001447028-24-000051.txt   331014
Mailing Address 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address 701 VETERANS CIRCLE WARMINSTER PA 18974 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9000 STATE ROAD PHILADELPHIA PA 19136
Business Address
Rewolinski Melissa (Reporting) CIK: 0001780206 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 24984407